NCT01005069View on ClinicalTrials.gov

Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

DLBS-32

DLBS-32 50 mg once daily and lifestyle modification

DRUG

DLBS-32

DLBS-32 100 mg once daily and lifestyle modification

DRUG

DLBS-32

DLBS-32 200 mg once daily and lifestyle modification

DRUG

DLBS-32

DLBS-32 300 mg once daily and lifestyle modification

DRUG

Placebo capsule

Placebo capsules once daily and lifestyle modification

Trial Locations (2)

Unknown

Sanglah Hospital Denpasar, Denpasar

RSUD Tarakan, Jakarta Pusat

Sponsors

Lead Sponsor

Dexa Medica Group
All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT01005069 - Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus | Biotech Hunter | Biotech Hunter